Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s Disease

11 Sept 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase and Neurodegenerative Diseases
Share to Histone Deacetylase Inhibitors Research
Share to Protein Degradation and Inhibitors

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 25219501
DOI: 10.1016/j.molcel.2014.08.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s DiseasePMID 25219501Read ↗

HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological DisordersSemantic proximity Read ↗

Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patientsSemantic proximity Read ↗

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic TargetingSemantic proximity Read ↗

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agentsSemantic proximity Read ↗

Multiple roles of HDAC inhibition in neurodegenerative conditionsSemantic proximity Read ↗

Histone Deacetylase Inhibition in Alzheimer’s Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesSemantic proximity Read ↗

HDACs in the Brain: From Chromatin Remodeling to Neurodegenerative DiseaseSemantic proximity Read ↗

Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer’s DiseaseSemantic proximity Read ↗

Cyclin C expression is involved in the pathogenesis of Alzheimer's diseaseSemantic proximity Read ↗

Epigenetics in Neurodegenerative Diseases: The Role of Histone DeacetylasesSemantic proximity Read ↗

Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer’s disease-related phenotypesSemantic proximity Read ↗

HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievementsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.